These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

345 related items for PubMed ID: 18177931

  • 1. Hemodynamic alterations in liver cirrhosis.
    La Villa G, Gentilini P.
    Mol Aspects Med; 2008; 29(1-2):112-8. PubMed ID: 18177931
    [Abstract] [Full Text] [Related]

  • 2. Vasoactive factors and hemodynamic mechanisms in the pathophysiology of portal hypertension in cirrhosis.
    Gatta A, Bolognesi M, Merkel C.
    Mol Aspects Med; 2008; 29(1-2):119-29. PubMed ID: 18036654
    [Abstract] [Full Text] [Related]

  • 3. Elevated nitric oxide levels in patients with chronic liver disease and cirrhosis correlate with disease stage and parameters of hyperdynamic circulation.
    Arkenau HT, Stichtenoth DO, Frölich JC, Manns MP, Böker KH.
    Z Gastroenterol; 2002 Nov; 40(11):907-13. PubMed ID: 12436367
    [Abstract] [Full Text] [Related]

  • 4. Splanchnic endotoxin levels in cirrhotic rats induced by carbon tetrachloride.
    Chu CJ, Lee FY, Wang SS, Chang FY, Lin HC, Lu RH, Chan CC, Lee SD.
    Zhonghua Yi Xue Za Zhi (Taipei); 2000 Mar; 63(3):196-204. PubMed ID: 10746415
    [Abstract] [Full Text] [Related]

  • 5. Tyrosine kinase inhibition ameliorates the hyperdynamic state and decreases nitric oxide production in cirrhotic rats with portal hypertension and ascites.
    López-Talavera JC, Levitzki A, Martínez M, Gazit A, Esteban R, Guardia J.
    J Clin Invest; 1997 Aug 01; 100(3):664-70. PubMed ID: 9239414
    [Abstract] [Full Text] [Related]

  • 6. Pathogenesis of water and sodium retention in cirrhosis.
    Martin PY, Schrier RW.
    Kidney Int Suppl; 1997 Jun 01; 59():S43-9. PubMed ID: 9185104
    [Abstract] [Full Text] [Related]

  • 7. Increased lipopolysaccharide binding protein in cirrhotic patients with marked immune and hemodynamic derangement.
    Albillos A, de la Hera A, González M, Moya JL, Calleja JL, Monserrat J, Ruiz-del-Arbol L, Alvarez-Mon M.
    Hepatology; 2003 Jan 01; 37(1):208-17. PubMed ID: 12500206
    [Abstract] [Full Text] [Related]

  • 8. Circulating nitric oxide products do not solely reflect nitric oxide release in cirrhosis and portal hypertension.
    Afzelius P, Bazeghi N, Bie P, Bendtsen F, Vestbo J, Møller S.
    Liver Int; 2011 Oct 01; 31(9):1381-7. PubMed ID: 21745317
    [Abstract] [Full Text] [Related]

  • 9. The molecules: mechanisms of arterial vasodilatation observed in the splanchnic and systemic circulation in portal hypertension.
    Iwakiri Y.
    J Clin Gastroenterol; 2007 Oct 01; 41 Suppl 3():S288-94. PubMed ID: 17975478
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Autonomic dysfunction and hyperdynamic circulation in cirrhosis with ascites.
    Trevisani F, Sica G, Mainquà P, Santese G, De Notariis S, Caraceni P, Domenicali M, Zacà F, Grazi GL, Mazziotti A, Cavallari A, Bernardi M.
    Hepatology; 1999 Dec 01; 30(6):1387-92. PubMed ID: 10573516
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Systemic circulatory hyperkinetic syndrome in patients with cirrhosis. Relation with hepatocellular failure and portal hypertension].
    Valla D, Poynard T, Bercoff E, Bataille C, Goldfarb G, Lebrec D.
    Gastroenterol Clin Biol; 1984 Apr 01; 8(4):321-4. PubMed ID: 6735039
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.